Clinical Trial Update: A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. [Phase 3]

View source ↗

Summary

A completed Phase 3 safety and efficacy trial of epoetin alfa in pre-dialysis patients with anemia due to kidney disease. The study, sponsored by Janssen-Ortho …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• Left Ventricular Hypertrophy

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: Anemia, Kidney Failure | Phase 3 | Status: COMPLETED